|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
70,540,000 |
Market
Cap: |
N/A |
Last
Volume: |
4,776,453 |
Avg
Vol: |
2,215,743 |
52
Week Range: |
$49.96 - $49.96 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pietrusko Robert |
VP, Regulatory & Quality |
|
2013-12-27 |
4 |
OE |
$5.91 |
$27,629 |
D/D |
4,675 |
37,253 |
|
- |
|
Soland Daniel B |
VP, Chief Operating Officer |
|
2013-12-27 |
4 |
D |
$49.86 |
$90,197 |
D/D |
(1,809) |
138,350 |
|
- |
|
Soland Daniel B |
VP, Chief Operating Officer |
|
2013-12-27 |
4 |
OE |
$5.91 |
$67,965 |
D/D |
11,500 |
140,159 |
|
- |
|
Rowland Charles A Jr |
VP, Chief Financial Officer |
|
2013-12-27 |
4 |
D |
$49.86 |
$35,101 |
D/D |
(704) |
64,722 |
|
- |
|
Rowland Charles A Jr |
VP, Chief Financial Officer |
|
2013-12-27 |
4 |
OE |
$5.91 |
$26,831 |
D/D |
4,540 |
65,426 |
|
- |
|
Soland Daniel B |
VP, Chief Operating Officer |
|
2013-12-18 |
4 |
D |
$49.74 |
$3,187,488 |
D/D |
(64,083) |
128,659 |
|
- |
|
Soland Daniel B |
VP, Chief Operating Officer |
|
2013-12-18 |
4 |
OE |
$5.91 |
$959,521 |
D/D |
120,784 |
175,213 |
|
- |
|
Rowland Charles A Jr |
VP, Chief Financial Officer |
|
2013-12-18 |
4 |
D |
$49.74 |
$1,249,916 |
D/D |
(25,129) |
60,886 |
|
- |
|
Rowland Charles A Jr |
VP, Chief Financial Officer |
|
2013-12-18 |
4 |
OE |
$5.91 |
$453,673 |
D/D |
49,006 |
72,721 |
|
- |
|
Dougherty Michael R |
Director |
|
2013-12-18 |
4 |
D |
$49.74 |
$34,221 |
D/D |
(688) |
20,812 |
|
- |
|
Dougherty Michael R |
Director |
|
2013-12-18 |
4 |
OE |
$3.42 |
$34,200 |
D/D |
10,000 |
21,500 |
|
- |
|
Pietrusko Robert |
VP, Regulatory & Quality |
|
2013-12-18 |
4 |
D |
$49.74 |
$1,252,851 |
D/D |
(25,188) |
32,578 |
|
- |
|
Pietrusko Robert |
VP, Regulatory & Quality |
|
2013-12-18 |
4 |
OE |
$5.91 |
$420,087 |
D/D |
49,911 |
49,989 |
|
- |
|
Wolf John Peter Iii |
VP, General Counsel |
|
2013-12-18 |
4 |
D |
$49.74 |
$2,969,279 |
D/D |
(59,696) |
40,983 |
|
- |
|
Wolf John Peter Iii |
VP, General Counsel |
|
2013-12-18 |
4 |
OE |
$5.91 |
$1,468,392 |
D/D |
100,227 |
45,574 |
|
- |
|
Fletcher Robert C. |
V.P., Business Development |
|
2013-12-18 |
4 |
D |
$49.74 |
$2,585,187 |
D/D |
(51,974) |
37,227 |
|
- |
|
Fletcher Robert C. |
V.P., Business Development |
|
2013-12-18 |
4 |
OE |
$5.91 |
$1,226,530 |
D/D |
88,972 |
46,425 |
|
- |
|
Milano Vincent |
President and CEO |
|
2013-12-18 |
4 |
D |
$49.74 |
$16,802,669 |
D/D |
(337,810) |
362,846 |
|
- |
|
Milano Vincent |
President and CEO |
|
2013-12-18 |
4 |
OE |
$5.91 |
$6,317,885 |
D/D |
586,310 |
393,579 |
|
- |
|
Leone John R |
Director |
|
2013-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
11,000 |
|
- |
|
Dougherty Michael R |
Director |
|
2013-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
11,500 |
|
- |
|
Pien Howard H |
Director |
|
2013-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
9,000 |
|
- |
|
Glaser Robert |
Director |
|
2013-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
45,860 |
|
- |
|
Mchugh Julie |
Director |
|
2013-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
6,583 |
|
- |
|
Claypool William D Md |
Director |
|
2013-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
49,000 |
|
- |
|
412 Records found
|
|
Page 3 of 17 |
|
|